Ibrahim Ragab Eissa

400 citations
12 papers · 307 indexed · h-index 8
Topics
Virus-based gene therapy research (8 papers)CAR-T cell therapy research (5 papers)Cancer Research and Treatments (4 papers)
Partner nations
JapanEgyptUnited States

In The Last Decade

Ibrahim Ragab Eissa

12 papers receiving 296 citations

Peers

Ibrahim Ragab Eissa
Comparison fields: 5 of 40
  • Genetics 198
  • Oncology 190
  • Molecular Biology 123
  • Immunology 69
  • Biotechnology 57
Replace Jiankai Liang with:
Jiankai Liang China
Shohei Miyamoto Japan
Toru Ichinose Japan
Amy Haseley United States
Jennifer Hickey United States
Dongling Gao China
Yves Poitevin Switzerland
Amy Denton United Kingdom
Hajime Kurosaki Japan
Petri Nokisalmi Finland
Ibrahim Ragab Eissa relative to Jiankai Liang China Jiankai Liang's profile →
Citations per field
00.5×1.5×
Jiankai Liang · 1×
Citations per year

Countries citing papers authored by Ibrahim Ragab Eissa

Since Specialization
Citations

This map shows the geographic impact of Ibrahim Ragab Eissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Ragab Eissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Ragab Eissa more than expected).

Fields of papers citing papers by Ibrahim Ragab Eissa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ibrahim Ragab Eissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Ragab Eissa. The network helps show where Ibrahim Ragab Eissa may publish in the future.

Co-authorship network of co-authors of Ibrahim Ragab Eissa

This figure shows the co-authorship network connecting the top 25 collaborators of Ibrahim Ragab Eissa. A scholar is included among the top collaborators of Ibrahim Ragab Eissa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ibrahim Ragab Eissa. Ibrahim Ragab Eissa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 3
2 6
3 7
4 27
5 11
6 2
7 17
8 8
9 25
10 121
11 78
12 2

About Ibrahim Ragab Eissa

Ibrahim Ragab Eissa is a scholar working on Biotechnology, Genetics and Immunology, having authored 12 papers that have together received 307 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Genetics (198 citations), Oncology (190 citations) and Biotechnology (57 citations). Ibrahim Ragab Eissa has collaborated with scholars based in Japan, Egypt and United States. Frequent co-authors include Hideki Kasuya, Yoshinori Naoe, Yasuhiro Kodera, Maki Tanaka, Nobuaki Mukoyama, Toru Ichinose, Noriyuki Miyajima, Shigeru Matsumura, Zhiwen Wu and Branko Aleksić. Their work appears in journals such as Scientific Reports, International Journal of Molecular Sciences and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026